Overall survival in MERiDiAN, a double-blind placebo-controlled randomised phase III trial evaluating first-line bevacizumab plus paclitaxel for HER2-negative metastatic breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 23 November 2017 |
| Author/s |
author: Joyce O'Shaughnessy |
| Publication date | November 23, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |